events, although there was an increased incidence of
bleeding complications associated with anticoagulation.127-129 A recent meta-analysis of eight clinical trials
comparing anticoagulation with antiplatelet therapy for
secondary prevention of stroke identiﬁed no difference
in prevention of vascular events.130
In addition to aspirin, clopidogrel, the combination
agent aspirin þ dipyridamole, and dual antiplatelet therapy